Sarah E. Pinder
#127,459
Most Influential Person Now
Researcher
Sarah E. Pinder's AcademicInfluence.com Rankings
Sarah E. Pinderengineering Degrees
Engineering
#4237
World Rank
#5422
Historical Rank
Electrical Engineering
#1058
World Rank
#1139
Historical Rank
Sarah E. Pindercomputer-science Degrees
Computer Science
#5423
World Rank
#5731
Historical Rank
Computational Linguistics
#753
World Rank
#766
Historical Rank
Machine Learning
#1441
World Rank
#1463
Historical Rank
Artificial Intelligence
#1672
World Rank
#1704
Historical Rank
Download Badge
Engineering Computer Science
Sarah E. Pinder's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Sarah E. Pinder Influential?
(Suggest an Edit or Addition)Sarah E. Pinder's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (2012) (4591)
- Pathological prognostic factors in breast cancer. (1999) (2290)
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes (2016) (1125)
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses (2005) (596)
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial (2018) (587)
- Expression of luminal and basal cytokeratins in human breast carcinoma (2004) (583)
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial (2010) (504)
- An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer (2007) (485)
- Terahertz pulsed spectroscopy of freshly excised human breast cancer. (2009) (430)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. (2008) (420)
- Histological grading of breast carcinomas: a study of interobserver agreement. (1995) (410)
- Patterns of somatic structural variation in human cancer genomes (2020) (377)
- Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer (2014) (358)
- High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer (2007) (326)
- Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis (2005) (280)
- Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up (1994) (280)
- Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?: A Morphological and Molecular Analysis (2005) (270)
- A gene-expression signature to predict survival in breast cancer across independent data sets (2007) (263)
- Addressing overtreatment of screen detected DCIS; the LORIS trial. (2015) (263)
- Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma (2004) (254)
- Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres (2003) (247)
- Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases (1995) (240)
- A model for predicting non‐sentinel lymph node metastatic disease when the sentinel lymph node is positive (2008) (236)
- Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. (2005) (235)
- Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index (2006) (235)
- Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line (2008) (233)
- Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. (2007) (212)
- Immunohistochemical detection of steroid receptors in breast cancer: a working protocol (2000) (211)
- Somatic mutations reveal asymmetric cellular dynamics in the early human embryo (2017) (204)
- Screening interval breast cancers: mammographic features and prognosis factors. (1996) (198)
- Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
- Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer (2003) (195)
- Updated UK Recommendations for HER2 assessment in breast cancer (2014) (195)
- Prognostic factors for patients with hepatic metastases from breast cancer (2003) (186)
- Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. (1995) (183)
- Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial (2014) (176)
- Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative orBRCA1/2breast cancer (CRUK/07/012) (2015) (174)
- Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. (2013) (169)
- Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma (1995) (168)
- A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. (1995) (167)
- The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome (2004) (166)
- Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. (2011) (165)
- E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance (2005) (163)
- Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others. (2016) (157)
- Neuroendocrine differentiation and prognosis in breast adenocarcinoma (2002) (156)
- Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. (2003) (156)
- An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. (2003) (156)
- Brain metastases from breast cancer: identification of a high-risk group. (2004) (151)
- Total loss of MHC class I is an independent indicator of good prognosis in breast cancer (2005) (146)
- Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. (2006) (146)
- Best Practice No 176 (2004) (144)
- Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features (2003) (141)
- The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification (2003) (137)
- Randomized clinical trial comparing radioisotope occult lesion localization and wire‐guided excision for biopsy of occult breast lesions (2004) (137)
- Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement (2000) (137)
- Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma (2003) (135)
- HER2 testing in the UK: further update to recommendations (2008) (135)
- C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. (1996) (133)
- Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy (2007) (126)
- Over-expression of ST3Gal-I promotes mammary tumorigenesis (2010) (121)
- A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial (2010) (119)
- Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. (1994) (119)
- X-ray refraction effects: application to the imaging of biological tissues. (2003) (118)
- Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers (2007) (118)
- c-erbB-4 protein expression in human breast cancer (2000) (115)
- Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer (2009) (111)
- Gamma linolenic acid with tamoxifen as primary therapy in breast cancer (1998) (110)
- An immunohistochemical examination of the expression of E‐cadherin, α‐ and β/γ‐catenins, and α2‐ and β1‐integrins in invasive breast cancer (1999) (106)
- Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team. (2001) (104)
- Geminin predicts adverse clinical outcome in breast cancer by reflecting cell‐cycle progression (2004) (104)
- The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy (1998) (103)
- Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3) (2003) (103)
- ONCOPOOL - a European database for 16,944 cases of breast cancer. (2010) (103)
- Regulation of p53 tetramerization and nuclear export by ARC (2006) (102)
- A consensus prognostic gene expression classifier for ER positive breast cancer (2006) (98)
- Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation (2010) (97)
- Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles (2013) (97)
- Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. (1998) (96)
- Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. (2015) (91)
- The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. (2011) (89)
- Processed pseudogenes acquired somatically during cancer development (2014) (87)
- E-cadherin as a prognostic indicator in primary breast cancer (2001) (86)
- Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice. (2017) (86)
- Classification of terahertz-pulsed imaging data from excised breast tissue. (2012) (85)
- Best Practice No 179 (2004) (84)
- Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study (2017) (83)
- RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers. (2017) (82)
- Impact of a national external quality assessment scheme for breast pathology in the UK (2006) (81)
- Preoperative assessment of prognostic factors in breast cancer (2001) (81)
- Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control (2013) (81)
- The positive predictive value of mammographic signs: a review of 425 non-palpable breast lesions. (1996) (79)
- The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumps. (1998) (79)
- Local recurrence after simple mastectomy (1994) (78)
- Prognostic significance of BRCA1 expression in sporadic breast carcinomas (2003) (77)
- Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? (2001) (77)
- Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast (2006) (77)
- Loss of CD59 expression in breast tumours correlates with poor survival (2003) (77)
- Upregulation of MICA on high-grade invasive operable breast carcinoma. (2007) (76)
- Predicting invasion in mammographically detected microcalcification. (2001) (76)
- Germline CDH1 mutations in bilateral lobular carcinoma in situ (2013) (76)
- False-negative breast screening assessment: what lessons can we learn? (2001) (73)
- NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). (2018) (73)
- A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH (2006) (71)
- The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. (1996) (69)
- HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods (2011) (69)
- Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? (2006) (67)
- Deposition of superparamagnetic iron‐oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection (2013) (67)
- Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer. (2016) (66)
- MYC amplification in breast cancer: a chromogenic in situ hybridisation study (2006) (66)
- Updated recommendations for HER2 testing in the UK (2004) (66)
- Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship. (2014) (66)
- PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion (2015) (65)
- Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy. (2015) (64)
- OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer. (2016) (63)
- Spindle cell carcinoma of the breast: a case series of a rare histological subtype. (2003) (62)
- Systematic review of high‐intensity focused ultrasound ablation in the treatment of breast cancer (2015) (61)
- Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. (2018) (60)
- Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue. (2017) (59)
- An audit of ‘equivocal’ (C3) and ‘suspicious’ (C4) categories in fine needle aspiration cytology of the breast (2001) (58)
- Reading the prognosis of the individual with breast cancer. (2007) (57)
- Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project (2010) (56)
- Breast cancer diagnosis using scattered X‐rays (2000) (56)
- Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. (2001) (56)
- Automated Classification of Breast Cancer Stroma Maturity From Histological Images (2017) (56)
- Patterns of metastatic breast carcinoma: influence of tumour histological grade. (2004) (55)
- Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. (1994) (55)
- Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. (2004) (54)
- Is ipsilateral mammography worthwhile in Paget's disease of the breast? (1996) (53)
- The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility (2014) (52)
- The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example (2012) (52)
- Loss of CD55 Is Associated with Aggressive Breast Tumors (2004) (52)
- Non-operative breast pathology: columnar cell lesions (2006) (51)
- Breast cancer diagnosis using scattered x rays? (2001) (51)
- Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes (2016) (50)
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
- Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium (2014) (49)
- Breast pathology practice: most common problems in a consultation service (2005) (49)
- Guidelines for breast needle core biopsy handling and reporting in breast screening assessment (2004) (48)
- Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer (2001) (47)
- Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. (1999) (47)
- Prognostic significance of serum c-erbB-2 protein in breast cancer patients (2005) (47)
- Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound. (1998) (47)
- Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial. (2013) (46)
- Expression of E2F‐4 in invasive breast carcinomas is associated with poor prognosis (2004) (46)
- Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer (2018) (46)
- The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer (2005) (46)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
- When have mammographic calcifications been adequately sampled at needle core biopsy? (2000) (46)
- Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? (2003) (46)
- Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast? (2010) (45)
- The expression of alpha B‐crystallin in epithelial tumours: A useful tumour marker? (1994) (45)
- Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells (2014) (45)
- The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation (2019) (45)
- Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. (2018) (44)
- Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. (2018) (44)
- Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. (2003) (43)
- Expression of p27kip1 in breast cancer and its prognostic significance (2003) (43)
- Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients (2018) (42)
- Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. (1999) (42)
- Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer (2004) (41)
- Sex differences in oncogenic mutational processes (2019) (41)
- P‐glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism (2007) (41)
- Prognostic factors in primary breast carcinoma. (1995) (41)
- Radiological features of papillary carcinoma of the breast. (1997) (40)
- Pure mucinous breast cancer-mammographic and ultrasound findings. (1996) (40)
- Lymphatic drainage pathways of the breast and the upper limb (2009) (40)
- Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings (2001) (39)
- Loss of Heterozygosity in Bilateral Breast Cancer (2000) (39)
- A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer (2014) (38)
- Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team. (1993) (37)
- A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going? (1999) (37)
- Breast implant‐associated anaplastic large cell lymphoma (BIA‐ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management (2019) (37)
- The role of pre‐operative diagnosis in breast cancer (1996) (37)
- Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)? (2005) (36)
- An intra-operative THz probe for use during the surgical removal of breast tumors (2008) (35)
- Non-operative breast pathology: lobular neoplasia (2006) (35)
- Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody (1997) (35)
- HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment. (2002) (35)
- Clinical Value of Epidermal Growth Factor Receptor Expression in Primary Breast Cancer (2005) (34)
- Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1 (2004) (34)
- Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. (2013) (34)
- A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. (2012) (34)
- Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value (2005) (34)
- The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours. (1997) (33)
- Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model (2015) (33)
- Review of the national external quality assessment (EQA) scheme for breast pathology in the UK (2016) (33)
- Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer (2021) (32)
- Current issues in diagnostic breast pathology (2012) (32)
- Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates (1997) (32)
- Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management (2007) (32)
- Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value? (2004) (32)
- Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value (2015) (31)
- Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule (2015) (31)
- C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer. (1998) (30)
- Mucins in prostatic carcinoma (1990) (30)
- Predictors of response to second-line endocrine therapy for breast cancer (1997) (30)
- Consolidated criteria for reporting qualitative research guidelines (2016) (29)
- Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. (2016) (29)
- Endocrine response and resistance in breast cancer: a role for the transcription factor Fos (1999) (28)
- Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. (1996) (28)
- Pathological-radiological correlations in benign lesions excised during a breast screening programme. (1994) (28)
- High‐resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry (2005) (27)
- The pathological and radiological features of screen-detected breast cancers diagnosed following arbitration of discordant double reading opinions. (2005) (27)
- Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up (2007) (27)
- Correlations between the mammographic features of screen detected invasive breast cancer and pathological prognostic factors (1997) (27)
- Family history of breast cancer and its association with disease severity and mortality (2016) (26)
- The significance of p53 autoantibodies in the serum of patients with breast cancer. (1996) (26)
- The radiological appearances of invasive cribriform carcinoma of the breast. Nottingham Breast Team. (1994) (26)
- HER2 status in breast cancer–an example of pharmacogenetic testing (2007) (26)
- Patterns of metastatic spread in early breast cancer. (2013) (25)
- Streptococcal perianal infection in children (2009) (25)
- High intensity focused ultrasound in the treatment of breast fibroadenomata: results of the HIFU-F trial (2016) (25)
- Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. (2019) (25)
- Macroscopic handling and reporting of breast cancer specimens pre‐ and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches (2015) (25)
- Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype (2020) (24)
- The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. (2016) (24)
- The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations (1995) (24)
- HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status (2016) (24)
- Implications of Inconsistent Measurement of ER Status in Non‐Invasive Breast Cancer: A Study of 1,684 Cases from the Sloane Project (2008) (23)
- Successful management of elderly breast cancer patients treated without radiotherapy (2007) (23)
- Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy. (2015) (23)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium (2014) (23)
- An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment (2018) (23)
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
- Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer (2021) (22)
- Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme (2017) (22)
- Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project (2020) (22)
- Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers (2018) (22)
- Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. (2014) (22)
- High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer (2007) (21)
- A Grounded Theory of Bisexual Individuals’ Experiences of Help Seeking (2017) (21)
- Invasive Lobular Carcinoma of the Breast. (2012) (21)
- Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ. (2015) (21)
- Preliminary observations of breast tumor collagen (1999) (20)
- Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project. (2010) (20)
- Pre-operative diagnosis of breast cancer in screening: problems and pitfalls. (2009) (20)
- Phenotypic similarities in bilateral breast cancer (2004) (20)
- Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study (2016) (20)
- "Inflammatory" breast cancer. (2005) (19)
- Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model (2013) (19)
- The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal (2006) (19)
- Digital imaging improves upright stereotactic core biopsy of mammographic microcalcifications. (2000) (19)
- Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1. (2004) (19)
- Diffraction-enhanced imaging: improved contrast and lower dose x-ray imaging (2002) (19)
- Spatial genomics maps the structure, character and evolution of cancer clones (2021) (19)
- Breast Cancer with Neoductgenesis: Histopathological Criteria and Its Correlation with Mammographic and Tumour Features (2014) (18)
- Micro- and macro-metastasis in the axillary lymph node: A review. (2017) (18)
- Invasion in breast lesions: the role of the epithelial–stroma barrier (2018) (18)
- Autoantibodies in early breast cancer (2005) (18)
- Diagnostic concordance of reporting lymphovascular invasion in breast cancer (2018) (18)
- Terahertz spectroscopy of breast tumors (2007) (18)
- Pathological assessment of sentinel lymph-node biopsies in patients with breast cancer (2000) (17)
- Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer (2014) (17)
- Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression (2020) (17)
- HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice (2013) (17)
- The Role of Blood Tumor Marker Measurement (Using a Biochemical Index Score and C-Erbb2) in Directing Chemotherapy in Metastatic Breast Cancer (2000) (17)
- Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial (2016) (17)
- Are Medullary Breast Cancers an Indication for BRCA1 Mutation Screening? A Mutation Analysis of 42 Cases of Medullary Breast Cancer (2004) (16)
- Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer (2020) (16)
- Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer (2019) (16)
- Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis (2015) (16)
- Prognostic factors in invasive carcinoma of the breast. (1998) (16)
- Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer (2022) (16)
- An audit of residual cancer burden reproducibility in a UK context (2017) (16)
- Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. (2018) (15)
- Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years (2019) (15)
- Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival (2017) (15)
- Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time (2015) (15)
- Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens. (2013) (15)
- PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression (2017) (14)
- Accuracy of mammography in predicting histological extent of ductal carcinoma in situ (DCIS). (2006) (14)
- Abstract S6-01:BRCA1methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) (2017) (14)
- Comparative Immunohistochemical Analysis of Ochratoxin A Tumourigenesis in Rats and Urinary Tract Carcinoma in Humans; Mechanistic Significance of p-S6 Ribosomal Protein Expression (2012) (14)
- Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (2013) (14)
- Reporting needle core biopsies of breast carcinomas (2003) (13)
- Fibroepithelial Lesions, Including Fibroadenoma and Phyllodes Tumors (2011) (13)
- Is mammography of value in women with disseminated cancer of unknown origin? (1999) (13)
- High-intensity focused ultrasound in the treatment of breast fibroadenomata (HIFU-F trial) (2018) (13)
- Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients (2018) (13)
- Fibroadenomatoid hyperplasia: a cause of suspicious microcalcification on mammographic screening. (1998) (13)
- The B3 conundrum-the radiologists' perspective. (2017) (13)
- Detecting which invasive cancers at mammographic screening saves lives? (2001) (12)
- Application of Finite Difference Time Domain methods to Terahertz Spectroscopy Measurements of Breast Cancer (2007) (12)
- A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. (2012) (12)
- Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate (2020) (12)
- Beneficial Effect of Tamoxifen for Women with DCIS: Long-Term Results from the UK/ANZ DCIS Trial in Women with Locally Excised DCIS. (2009) (12)
- Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins? (2017) (12)
- Needle core biopsy of the breast (2000) (12)
- When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node? (2014) (12)
- Precursor lesions of breast carcinoma (1993) (11)
- An audit of grading and typing of invasive breast carcinoma on needlecore biopsy specimens (1998) (11)
- Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast (2004) (11)
- Invasive Carcinoma: Special Types (2006) (11)
- Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma (2001) (11)
- Radiotherapy and/or Tamoxifen after conserving surgery for breast cancers of excellent prognosis: BASO II trial (2007) (10)
- Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast (2010) (10)
- Modern therapies and iatrogenic changes in breast pathology (2017) (10)
- Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial (2020) (10)
- Spatial genomics maps the structure, nature and evolution of cancer clones (2022) (10)
- Systematic review of clinical effectiveness of surveillance mammography after treatment for primary breast cancer (2011) (9)
- Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study (2010) (9)
- Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon (2019) (9)
- Telling (dangerous) stories: a narrative account of a youth coach’s experience of an unfounded allegation of child abuse (2017) (9)
- Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial (2021) (9)
- Variability in grading of ductal carcinoma in situ among an international group of pathologists (2021) (9)
- Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management (2020) (9)
- Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response? (2019) (9)
- A review of ablative techniques in the treatment of breast fibroadenomata (2016) (8)
- Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial (2017) (8)
- Mammographic and pathological features of breast cancer detected at first incident round screening (1997) (8)
- An Immunohistochemical and Fluorescence In Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United Kingdom HER2 IHC Scoring Guidelines (2010) (8)
- Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model. (2014) (8)
- Medical applications of broadband terahertz pulsed radiation (2005) (8)
- A comparison of 14 and 12 gauge needles for core biopsy of suspicious mammographic calcification. (1999) (8)
- PP-3-20 local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (dcis) of the breast (1996) (8)
- Recommendations for HER 2 assessment in breast cancer (2015) (7)
- Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial (2017) (7)
- Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial (2015) (7)
- HER 2-HER 3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER 2 IHC status (2016) (7)
- Terahertz pulsed imaging and spectroscopy of breast tumours (2006) (7)
- United Kingdom national audit of breast fine needle aspiration cytology in 1990–91‐organization and level of activity (1996) (7)
- Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type. (2004) (7)
- Multiple foci of invasive breast cancer: can breast MRI influence surgical management? (2011) (7)
- Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right. (2016) (7)
- Breast Pathology: A Volume in the Series: Foundations in Diagnostic Pathology (2011) (7)
- Wide local excision with 10 mm clearance without radiotherapy for DCIS (2001) (7)
- In the backyard (2006) (6)
- Preliminary observations of breast tumor collagen using synchrotron radiation (1999) (6)
- Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ (2021) (6)
- Prognostic significance of serum c-erbB2 protein in breast cancer patients (6)
- Pathological Examination of Sentinel Lymph Nodes: Work-Up – Interpretation – Clinical Implications (2007) (6)
- Oestrogen receptor expression in human breast cancer during long-term fulvestrant treatment. (2004) (6)
- Proliferative activity in invasive breast carcinoma. (1996) (6)
- Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study (2022) (6)
- Real‐time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study (2019) (6)
- Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer (2014) (6)
- Breast Pathology: A Volume in the Foundations in Diagnostic Pathology series (2011) (6)
- Brain metastases from breast cancer (2004) (6)
- Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma? (2017) (6)
- Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer (2010) (6)
- Small angle diffraction imaging for disease diagnosis (2005) (5)
- The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project (2022) (5)
- Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study) (2015) (5)
- THE ROLE OF PRE-OPEARIVE DIAGNOSIS IN BREAST CANCER (1996) (5)
- Assessment of variability in diagnosing "atypia" in columnar cell lesions (CCL) of the breast (2005) (5)
- Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment (2021) (5)
- UK national audit of breast fine needle aspiration cytology in 1990–91: diagnostic criteria (1996) (5)
- Bilateral breast carcinomas: do they have similar mammographic features? (1999) (5)
- Low‐grade adenosquamous carcinoma arising in association with a nipple adenoma (2019) (5)
- Molecular classification of breast carcinoma based on the protein expression immunoprofiles (2004) (5)
- The SMALL Trial: A Big Change for Small Breast Cancers. (2019) (5)
- The importance of histological assessment after neoadjuvant therapy and the need for standardisation. (2018) (5)
- Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node. (2013) (5)
- Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases (2021) (4)
- Chapter 20 – Invasive Carcinoma: Other Histologic Prognostic Factors – Size, Vascular Invasion and Prognostic Index (2006) (4)
- Chapter 17 – Morphology of Ductal Carcinoma in situ (2006) (4)
- Ductal carcinoma in situ: diagnosis and classification (2004) (4)
- Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication (2021) (4)
- Chapter 10 – Fibroepithelial Lesions, Including Fibroadenoma and Phyllodes Tumor (2006) (4)
- Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR) (2022) (4)
- Columnar cell lesions of the breast (2005) (4)
- Concordance of intrinsic subtyping and risk of recurrence (ROR) scores between matched primary and metastatic tissue from Triple Negative Breast Cancer Trial (TNT). (2015) (4)
- Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial (2021) (4)
- All-cause mortality rates (2011) (4)
- EASILY MISSED? : Streptococcal perianal infection in children (2009) (4)
- Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study (2017) (4)
- Pathological Nipple Discharge (2014) (4)
- The role of the pathologist in assessing prognostic factors for breast cancer (2008) (4)
- Modelling vasculature and cellular restriction in breast tumours using diffusion MRI (2014) (4)
- Immunohistochemistry for Triple-Negative Breast Cancer. (2016) (3)
- The impact of human epidermal growth factor receptor 2 neoadjuvant monoclonal antibody (trastuzumab) therapy in ductal carcinoma in situ of the breast (2017) (3)
- Ductal carcinoma in situ of the human breast: clinico-pathological aspects. (1999) (3)
- Guidelines for the handling of benign and malignant surgical breast specimens (2007) (3)
- Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer (2020) (3)
- Adenomyoepithelioma of the breast; a case report and literature review. (2005) (3)
- Classification of breast cancer stroma as a tool for prognosis (2016) (3)
- Reply to R.F. Sweis et al. (2017) (3)
- Reproducibility of cancer diagnosis using hair (2006) (3)
- OPTIMA: a prospective randomised trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions (2016) (3)
- Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane Project (2008) (3)
- In situ lobular proliferations of the breast (2018) (3)
- 1809 Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study (2015) (3)
- Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time (2016) (3)
- Abstract P3-17-06: LORIS trial of active monitoring for DCIS: How does the online pathology eligibility review process work? (2017) (3)
- Minimum slice spacing required to reconstruct 3D shape for serial sections of breast tissue for comparison with medical imaging (2015) (3)
- Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast (2016) (3)
- Expert opinion: Reporting needle core biopsies of breast carcinomas. (2003) (3)
- Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer (2015) (3)
- The SentiMAG multicentre trial: Sentinel node biopsy using a magnetic technique versus the standard technique (2013) (3)
- Delay to fixation of invasive breast carcinoma: Effect on mitotic count, MIB1, ER and P53 expression (2001) (3)
- Molecular biology (pre-clinical) (2012) (3)
- Original Article Brain Metastases from Breast Cancer: Identification of a High-risk Group (2004) (3)
- Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes (2022) (3)
- Reply to “Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project” (2021) (3)
- Comprar Breast Pathology, 2nd EditionA Volume in the Foundations in Diagnostic Pathology series (Expert Consult - Online and Print) | Frances P. O'Malley | 9781437717570 | Saunders (2011) (3)
- O-88 Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990 to 1999 (2007) (2)
- Abstract P2-08-02: Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer (2019) (2)
- Muir's Textbook of Pathology (1959) (2)
- A first in human feasibility study of 18F-FDG Cerenkov luminescence imaging (CLI) for intraoperative assessment of tumour resection margins in breast-conserving surgery (BCS) (2016) (2)
- OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions. (2016) (2)
- Breast: Ductal Carcinoma In Situ (DCIS) (2011) (2)
- O-70 The role of sentinel node biopsy in patients with a pre-operative diagnosis of ductal carcinoma in situ (2007) (2)
- Ductal carcinoma in situ: current morphological and molecular subtypes (2012) (2)
- Atypical ductal hyperplasia, ductal carcinoma in situ and in situ atypical apocrine proliferations of the breast (1996) (2)
- Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study) (2022) (2)
- 98. Mammographic features of interval cancers and prognosis compared with screen detected and symptomatic breast cancers (1995) (2)
- Bilateral Inflammatory Pseudotumour of the Breast: A Case Report and Review of the Literature. (2018) (2)
- Correlation between immunohistochemical and fish analysis for HER-2 in 441 breast carcinomas from multiple hospitals (2001) (2)
- O-91 Prognostic estimation: re-analysis of data from cases diagnosed in 1990–99 by Cox proportional hazards method (2007) (2)
- O-68 The incidence of nodal involvement following completion axillary dissection for sentinel node positive disease (2007) (2)
- PP-4-35 Breast screening for women aged < 50 — results from a family history clinic (1996) (2)
- Ultrasound-guided axillary node core biopsy in the staging of newly diagnosed breast cancer (2008) (2)
- Abstract P4-07-04: Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS (2020) (2)
- A Long Breast Cancer Remission without Standard Therapy (2015) (2)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium: Automated scoring of breast tumor TMAs (2014) (2)
- O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI) (2007) (2)
- OPTIMA: a randomised feasibility study of personalised care in the treatment of women with early breast cancer (2016) (2)
- Flap recurrence following simple mastectomy: an audit (1993) (2)
- High intensity focused ultrasound (HIFU) ablation in the treatment of breast cancers: A systematic review (2014) (2)
- Adenomyoepithelioma of the breast (2005) (2)
- Which patients benefit from intra-operative assessment of sentinel nodes? (2011) (2)
- 0-107/0-108. The UKCCCR breast screening frequency trial: results on predicted mortality (1997) (1)
- Modelling Vascularity in Breast Cancer and Surrounding Stroma Using Diffusion MRI and Intravoxel Incoherent Motion (2014) (1)
- A New Pathological Response Index (PRI) for Neoadjuvant Chemotherapy Accurately Predicts Clinical Outcomes of Locally Advanced Primary Breast Cancers (LAPBC) (2011) (1)
- Pathological-radiological correlations in ductal carcinoma in situ (DCIS) (1993) (1)
- Lympo-vascular invasion (LVI) and prognosis in invasive breast cancer (2002) (1)
- The rates of growth of breast cancers (2004) (1)
- Addendum to BASOII Trial report. (2014) (1)
- Thursday, 17 April 2008 12:30–14:30POSTER SESSIONDuctal and lobular carcinoma in situPosterThe role of sentinel node biopsy in patients with a pre-operative diagnosis of ductal carcinoma in situ (2008) (1)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
- Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71] (2010) (1)
- Abstract PS6-36: The formation of GCs in cancer-free ALNs, a non-monotonic prognostic factor in HR-negative invasive breast cancer patients (2021) (1)
- ‘Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients’ (2020) (1)
- Experts and performance in histopathology--a study in breast pathology. (2010) (1)
- Contrast-enhanced refraction imaging (2004) (1)
- Lyve-1 expressing perivascular macrophages orchestrate pericyte expansion to sustain angiogenesis in cancer (2020) (1)
- 2007 JOINT 32ND INTERNATIONAL CONFERENCE ON INFRARED AND MILLIMETER WAVES AND 15TH INTERNATIONAL CONFERENCE ON TERAHERTZ ELECTRONICS, VOLS 1 AND 2 (2007) (1)
- Young age is not an independent prognostic factor (2006) (1)
- HER-2 as an independent prognostic factor in node negative cases (2004) (1)
- The prognoses of tumours detected in the UK breast screening programme (NHS BSP) analysed by the Nottingham Prognostic Index (NPI) (2004) (1)
- 0-20. Local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (DCIS) of the breast (1997) (1)
- Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication (2021) (1)
- OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions (2016) (1)
- Are you a typer, grader or a molecular convert? Prognostic assessment of operable breast carcinoma (1992) (1)
- Comments on Synchrotron fibre diffraction identifies and locates foetal collagenous breast tIssue associated with breast carcinoma by V. J. James (2002). J. Synchrotron Rad. 9, 71-76. (2003) (1)
- High intensity focused ultrasound in the treatment of breast fibroadenomata: Results of the HIFU-F feasibility trial (2016) (1)
- Assessments of cancer-free lymph nodes for the prediction of disease progression (2019) (1)
- O-69 Axillary recurrence in breast cancer patients after a negative sentinel lymph node biopsy (2007) (1)
- Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland (2021) (1)
- Sloane Project: a prospective audit of screen detected ductal carcinoma in situ (2002) (1)
- Abstract P6-06-03: Differing patterns of treatment effect in a trial assessing sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT) (2013) (1)
- 5. The use of a handheld Terahertz pulsed imaging device to differentiate benign and malignant breast tissue with a view to reducing re-operation rates in breast-conserving surgery (2015) (1)
- Invasive micropapillary carcinoma of breast: case report with literature review. (2005) (1)
- Epidermal Growth Factor Receptor (EGFR) expression: Prognostic value in breast cancer patients with long-term follow-up (2001) (1)
- Factors underlying the improvement in mortality from breast cancer (2001) (1)
- Abstract OT3-02-12: OPTIMA (optimal personalised treatment of early breast cancer usIng multi-parameter analysis), a prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions (2016) (1)
- Disparity between Ki67 measurements and tumor gene expression tests in patients with hormone-sensitive early breast cancer from the OPTIMA preliminary trial. (2022) (1)
- Abstract OT1-03-01: The UK LORIS trial: Randomizing patients with low or low intermediate grade ductal carcinoma in situ (DCIS) to surgery or active monitoring (2017) (1)
- Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
- Patient information sheet and consent form (2016) (1)
- Lymphatic mapping and sentinel lymph node biopsy in an in-vivo porcine model using a novel magnetic technique (2013) (1)
- Selective use of post-mastectomy flap irradiation in high-risk breast cancer patients. (2005) (1)
- Age is not an independent prognostic factor (2001) (1)
- A randomized controlled trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with breast carcinoma of high estrogen receptor content: Long-term results at 20 years of follow-up. (2011) (1)
- 105. Sentinel lymph node biopsy for melanoma using a magnetic technique: Primary outcome of the MELAMAG Multicentre Trial (2014) (1)
- P094. Clinical feasibility of Cerenkov Luminescence Imaging (CLI) for intraoperative assessment of tumour excision margins and sentinel lymph node metastases in breast-conserving surgery (2015) (1)
- Chapter 25 – Overview of Immunohistochemistry in Breast Lesions (2006) (1)
- Prospective randomised study comparing radio-guided surgery (ROLL) to wire-guidance for occult breast lesions localisation (2001) (1)
- Abstract P1-06-07: Characterization of chromosomal instability in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) (2019) (1)
- Low-risk DCIS. What is it? Observe or excise? (2021) (1)
- Abstract OT1-06-02: SMALL - Open surgery versus minimally invasive vacuum-assisted excision for small screen detected breast cancer: A phase 3 randomised trial (2022) (1)
- Abstract P4-06-05: Heterogeneity of DCIS does not appear to be a biomarker for development of subsequent invasive cancer (2020) (1)
- A comparison of the mammographic features of screening detected and symptomatic ductal carcinoma in situ (DCIS) (1993) (1)
- Treatment and outcomes from a large, prospective, national longitudinal cohort study of screen detected ductal carcinoma in situ (DCIS). (2016) (1)
- Description of mammography surveillance regimens for women following mastectomy (2011) (0)
- O-71 Rescoring of grade and re-evaluation of the Nottingham Prognostic Index (NPI) using components of Elston Ellis grade and adding lympho-vascular invasion (2010) (0)
- UK recommendations for HER2 assessment in breast cancer: an update (2022) (0)
- Abstract PR002: Genomic predictor can discriminate between high- and low-risk DCIS (2022) (0)
- Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients (2018) (0)
- Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in the TNT trial (2020) (0)
- Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value (2015) (0)
- Volume Index (2003) (0)
- Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study (2017) (0)
- Histological risk factors, prognostic indicators (2005) (0)
- Breast Cancer: Pathology: ductal carcinoma in situ and lesions of uncertain malignant potential (2010) (0)
- lesionsbreast pathology: columnar cell (2009) (0)
- Survival after ductal carcinoma in situ (DCIS) (2001) (0)
- Estimates of the different types of cancer that exist (2011) (0)
- Qualitative research study interview schedule (final version used) (2016) (0)
- Editorial (2008) (0)
- Edinburgh Research Explorer Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50years (2019) (0)
- O-9 ONCOPOOL – A European Database in 16,893 cases of breast cancer: comparison with SEER (2007) (0)
- Chapter 17: Morphology of DCIS (2011) (0)
- Recurrence Data on 373 Cases of Lobular Carcinoma in Situ (LCIS) from the GLACIER Study (2015) (0)
- Abstract P5-13-01: Transcript analysis of PI3K and immune-related genes and gene signatures in the pre- and post-treatment samples from the window of opportunity study of anastrozole and anastrozole with pictilisib (GDC-0941) in patients with HR-positive early breast cancer (OPPORTUNE study) (2016) (0)
- Predictors for metastatic spread, survival and the impact of age in breast cancer (2013) (0)
- Immunohistochemical Profiling of Ductal Carcinoma In Situ of the Breast (2011) (0)
- March 2004 (2004) (0)
- Is completion axillary lymph node dissection necessary in the presence of metastasis in the sentinel lymph node (2013) (0)
- Chapter 11 – Benign Stromal Lesions of the Breast (2006) (0)
- Abstract A017: Epigenetic activation of SOX11 is associated with recurrence and progression of DCIS to invasive breast cancer (2022) (0)
- NOVEL OPTICAL PROTEOMICS MOLECULARLY PROFILES BREAST CANCER PATIENTS LEADING TO INDIVIDUALISED PROGNOSIS AND TAILORED TREATMENT (2009) (0)
- O-89 The effect of HER-2 overexpression on survival in early breast cancer (2007) (0)
- Prognostic and predictive factors in breast cancer (2008) (0)
- The use of a handheld Terahertz pulsed imaging device to differentiate benign and malignant breast tissue with a view to reducing re-operation rates in breast- conserving surgery – a first-in-human feasibility study (2017) (0)
- Ex vivo terahertz pulsed imaging to differentiate malignant from normal breast tissue (2009) (0)
- Erratum to: Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial (2016) (0)
- Self Assessment. Pathology of the breast (2008) (0)
- Univariate Cox regression models for the WMCIU cohorts (2011) (0)
- Abstract OT1-05-02: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in high clinical risk early breast cancer (2019) (0)
- A29 Lymphatic drainage pathways of the breast and upper limb (2006) (0)
- Invasive micropapillary carcinoma of the breast (2000) (0)
- Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium (2014) (0)
- Quality assessment of individual studies included in the systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- SNP-LOH Analysis of Lobular Carcinoma In Situ and Associated Invasive Lobular Cancer. (2009) (0)
- Developing and evaluation of a new clinicopathologic response index after neoadjuvant chemotherapy as a predictor of clinical outcomes in locally advanced breast cancers. (2014) (0)
- Screening detects a myriad of breast disease - refining practice will increase effectiveness and reduce harm. (2020) (0)
- Power doppler vascularity in malignant breast tumours: Correlation with pathological blood vessel counts, microvessel density and other histopathological prognostic factors (1998) (0)
- 657 Effects of Fulvestrant on oestrogen receptor levels during long-term treatment of patients with advanced breast cancer (2004) (0)
- EXPRESSION OF HORMAD1, A CANCER/TESTIS ANTIGEN, IN TRIPLE-NEGATIVE BREAST CANCERS WITH HIGH GENOMIC INSTABILITY (2012) (0)
- Epidermal Growth Factor Receptor Status in Operable Invasive Breast Cancer (2004) (0)
- Histology of cancers detected and not detected (true-positives and false-negatives): systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC (2011) (0)
- Immunohistochemical Expression of CD44 and CD24 in Ductal Carcinoma In Situ of the Breast (2012) (0)
- Improved prognosis for breast cancer across the prognostic spectrum from improved therapeutic management (2004) (0)
- Methods: pathology and health economic study (2016) (0)
- Number and percentage of respondents completing questions in the survey of UK surveillance mammography practice after treatment for primary breast cancer (2011) (0)
- OPTIMA prelim: Optimal personalized treatment of early breast cancer using multiparameter tests. (2013) (0)
- Pathology of High-Risk Breast Lesions (2018) (0)
- Additional details of the multiparameter tests (2016) (0)
- Immune-stroma-histological (ISH)-risk score identifies low-risk group within LN-positive breast cancers. (2017) (0)
- Exploration of utility of combined optical photothermal infrared and Raman imaging for investigating the chemical composition of microcalcifications in breast cancer (2023) (0)
- 0-58. Does incident round screening work? A comparison of prognostic factors of prevalent and incident carcinoma (1997) (0)
- Abstract P5-02-05: Variability in ductal carcinoma in situ grading among an international group of pathologists (2020) (0)
- List of NHS trusts of respondents to the survey of UK surveillance mammography practice after the treatment for primary breast cancer (2011) (0)
- Non-operative diagnosis has become the norm in breast disease assessment and , until relatively recently , fine needle aspiration cytology (2004) (0)
- Fine needle aspiration (FNA) cytology of breast: refining the diagnosis. (1998) (0)
- NIHMS662581-supplement-Supplementary data (2016) (0)
- 33PTHE PIM1 KINASE SHOWS GENOME DRIVEN UPREGULATION, SUPPRESSES APOPTOSIS, ENABLES COLONY FORMATION AND CELL MIGRATION AND IS A POTENTIAL TARGET IN TRIPLE-NEGATIVE BREAST CANCER (2013) (0)
- Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment (2021) (0)
- Evaluation of Nucleic Acid Quality From Long-Time Stored Fresh-Frozen Breast Cancer Tissues After Non-Automated Needle Micro-Dissection. (2011) (0)
- Detailed findings from qualitative recruitment study phase 1: understanding recruitment issues in the OPTIMA prelim study (2016) (0)
- Pathology of the breast (2008) (0)
- Abstract P1-01-27: SentiMAG multicentre trial*: Comparison of sentinel node biopsy identification rates using a magnetic tracer vs. standard technique. * UKCRN ID 12178 (UK); NTR 3283 (Netherlands) (2013) (0)
- Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia (2022) (0)
- Health utility literature review (2016) (0)
- E-mail invitation to participate in a survey of UK surveillance mammography practice after treatment for primary breast cancer (2011) (0)
- 44. p53 overexpression in breast carcinoma: an expression of tumour dedifferentiation? (1995) (0)
- Abstract P2-10-29: Time dependent breast cancer metastasis prediction using novel biological imaging, clinico-pathological and genomic data combined with Bayesian modeling to reduce over-fitting and improve on inter-cohort reproducibility. (2012) (0)
- Abstract LB-190: Growth hormone signaling in mammary stem and progenitor cells (2012) (0)
- Diagnostic, predictive and prognostic breast pathology. Editorial. (2008) (0)
- Breast carcinoma with neoductgenesis : a new subgroup of breast cancer (2012) (0)
- 145 A rescoring of Elston-Ellis Grade improves prognostic discrimination and consistency (2010) (0)
- Abstract P1-22-01: Predictors of inaccurate pre-operative size assessment of screen detected DCIS and impact on recurrence rates (2022) (0)
- Search strategies: systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- Quality assessment of individual studies included in the systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC (2011) (0)
- A novel application of magnetic nanotechnology for lesion localization and concurrent sentinel lymph node biopsy in breast cancer (2015) (0)
- Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer (2020) (0)
- Abstract P4-15-04: A longitudinal cohort study to identify risk factors for the development of invasive cancer in unresected DCIS (2018) (0)
- MULTISCALE BIPHASIC MODELLING OF TUMOUR GROWTH: THE EFFECT OF COLLAGEN MICROMECHANICS ON DRUG DELIVERY (2016) (0)
- SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancers. (2022) (0)
- Genomic Complexity Profi ling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Defi ciency in Triple-Negative Breast Cancers (2015) (0)
- Breast Cancer Pathology – DCIS and lesions of uncertain malignant potential (2010) (0)
- Abstract P4-02-22: Breast microcalcification chemistry predicts DCIS prognosis (2023) (0)
- 0-67. Automated grading in a prognostic index (1997) (0)
- Breast Pathology (1991) (0)
- Abstract PS16-03: Clonal relatedness of LCIS with synchronous and asynchronous invasive disease (2021) (0)
- Handling of Surgical Specimens (2011) (0)
- Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years (2019) (0)
- Abstract PD10-06: PD10-06 Clinical outcomes and exploratory gene expression analysis of OPPORTUNE: a phase II window-of-opportunity study to evaluate pictilisib+anastrozole versus anastrozole alone in ER-positive breast cancer (2023) (0)
- April 2004 (2004) (0)
- Questionnaire content: a survey of UK surveillance mammography practice after treatment for primary breast cancer (2011) (0)
- Membership and individual area of expertise of the project Advisory Group (2011) (0)
- Abstract 113: Lyve-1 expressing macrophages direct the expansion of pericytes within the perivascular niche to support angiogenesis in cancer (2021) (0)
- Abstract PD6-7: Pathological features and lessons learned from screen detected ductal carcinoma in situ (DCIS) - Results from 11 337 cases in the UK Sloane project (2020) (0)
- Univariate Cox regression models for the Edinburgh cohort (2011) (0)
- Additional file 3: of Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study (2017) (0)
- Chapter 3 – Assessment of Fine Needle Aspiration Cytology and Core Biopsy Samples (2006) (0)
- How repoducible is the diagnosis of flat epithelial atypia of the breast (2005) (0)
- Chapter 11: Benign stromal lesions (2011) (0)
- What constitutes an adequate margin of excision in breast-conserving surgery? (2010) (0)
- LEA 135 expression in primary invasive breast cancer (2002) (0)
- 54. The assessment of multiple variables on preoperative opeast carcinoma fine needle aspiration cytology specimens (1995) (0)
- Young male breast cancer - A case report and review of the literature (2005) (0)
- Excluded studies: systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- Abstract A016: Identification of methylated regions in ductal carcinoma in situ and association with disease progression (2022) (0)
- Characteristics of the studies included in the systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- Histological risk factors, prognostic indicators and staging (2013) (0)
- Terahertz Pulsed Imaging to differentiate benign and malignant breast tissue (2016) (0)
- Magnetic sentinel node and occult lesion localization (MagSNOLL) in an in vivo porcine model (2013) (0)
- High intensity focused ultrasound (HIFU) in the treatment of breast fibroadenomata: a feasibility study (2015) (0)
- 37. Tamoxifen therapy for stage III breast cancer: report on two randomized trials (1995) (0)
- C-erbB-2 in lymph node negative breast cancer: Prognostic significance in univariate and multivariate analyses (2001) (0)
- erbB Signalling in breast cancer (2007) (0)
- O-77 Incidental malignant breast disease in routine breast reduction specimens (2007) (0)
- Abstract OT1-06-01: OPTIMA: A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer (2018) (0)
- Reports of included studies: systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- The Importance of Post Neoadjuvant Histological Assessment and Need for Standardisation (2017) (0)
- Results: recruitment and study conduct (2016) (0)
- The mammographic features of papillary carcinoma of the breast (1994) (0)
- Can we manage B3 lesions better? (2008) (0)
- Chapter 2: Handling of surgical specimens (2011) (0)
- Magnetic 'V' conventional technique for sentinel lymph node biopsy in breast cancer (2011) (0)
- 0-41. An update on breast screening for women aged < 50: results from a family history clinic (1997) (0)
- O-105 erbB Signalling in breast cancer (2007) (0)
- March 2005 (2005) (0)
- Limitations of the qualitative research study methods (2016) (0)
- Histological characteristics of localized DCIS: observations from the UKCCCR DCIS Trial (1999) (0)
- Identifying feasible UK management strategies for surveillance mammography and follow-up of women after treatment for primary breast cancer (2011) (0)
- Atlas of breast cancer (1995) (0)
- Quality assessment tool used in the systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC (2011) (0)
- Problematic Core Biopsies (2017) (0)
- Prognostic significance of membrane cofactor protein (CD46) on breast tumors. (2004) (0)
- Abstract P3-12-36: The diagnosis and prognosis of ductal carcinoma in situ (DCIS) with microinvasion - Results from the United Kingdom Sloane project (2022) (0)
- Review of management guidelines for breast cancer (2011) (0)
- Methods used for multiparameter assay cost-effectiveness literature review (2016) (0)
- PP-6-7 Automated grading in a prognostic index (1996) (0)
- February 2005 (2005) (0)
- Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ (2019) (0)
- Description of mammography surveillance regimens for women following breast-conserving surgery (2011) (0)
- Normothermic Ex-Vivo Perfusion of Human Lymph Nodes: A Feasibility Study (2019) (0)
- Breast calcification micromorphology classification (2022) (0)
- Colour and power Doppler in the differential diagnosis of breast tumours: Correlation with microvessel density and blood vessel counts (1998) (0)
- The OPTIMA prelim guidance for recruiters (2016) (0)
- Diffusion anisotropy in breast cancer tissue corresponds to spatial patterns of collagen alignment from structure tensor analysis of histology (2017) (0)
- Chapter 10: Fibroepithelial lesions (2011) (0)
- Diagnosis and treatment of screen detected breast cancer (2008) (0)
- Invited Editorial (1998) (0)
- Reports of excluded studies: systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC (2011) (0)
- The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer (2022) (0)
- Histological grading of breast carcinoma: inter- and intraobserver studies (1994) (0)
- Summary of data from Adjuvant! Online used – estimated 10-year survival (2011) (0)
- Results: pathology and health economic study (2016) (0)
- Abstract P2-08-07: Predicting DCIS prognosis using infrared and raman spectroscopy of breast calcifications and soft-tissue microstructure (2022) (0)
- Young age and prognosis in invasive breast cancer (2002) (0)
- Qualitative research study profiles (2016) (0)
- 2008 33RD INTERNATIONAL CONFERENCE ON INFRARED, MILLIMETER AND TERAHERTZ WAVES, VOLS 1 AND 2 (2008) (0)
- The prediction of response to chemotherapy in invasive breast carcinoma by determination of histological grade (1998) (0)
- PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression (2017) (0)
- 51. Angiogenesis in human breast carcinoma (1995) (0)
- Evaluation of DNA repair biology signatures to predict specific carboplatin (C) versus docetaxel (D) benefit in advanced triple-negative breast cancer (aTNBC). (2020) (0)
- recommendationstesting in the UK: further update to (2008) (0)
- Analysis of Breast Cancer Registry database (2011) (0)
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial (2018) (0)
- Abstract P5-01-01: Multiscale Deep Learning framework to capture systemic immune features in lymph nodes predictive of triple negative breast cancer outcome (2023) (0)
- Additional file 6: Table S3. of Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study (2017) (0)
- List of questions used to help define alternative care pathways (2011) (0)
- Qualitative research study prior relationship/contact with research participants (2016) (0)
- 80. Sentinel lymph node identification rate in melanoma: A comparison of the standard and magnetic techniques in different lymphatic basins (2014) (0)
- Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial (2023) (0)
- Chapter 20: Invasive Carcinoma: Other Histologic Prognostic Factors, Prognostic Indices, and Application of Prognostic Information for Patient Management (2011) (0)
- Abstract P6-05-17: Recruitment challenges in a UK surgical de-escalation study: preliminary qualitative research findings from the SMALL trial (2023) (0)
- O-55 Assessment of Her-2 status using a panel of antibodies and FISH (2007) (0)
- Leaders Prognostic factors in primary breast carcinoma (0)
- An Overview of Immunohistochemistry in Diagnosis of Breast Lesions (2011) (0)
- Chapter 2 – Diagnostic Methodologies: Core Biopsy and Handling of Surgical Specimens (2006) (0)
- January 2005 (2004) (0)
- 2007 IEEE/MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM DIGEST, VOLS 1-6 (2007) (0)
- Proliferative Breast Lesions (2017) (0)
- Data extraction form for the systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- A multi-modal exploration of heterogeneous physico–chemical properties of DCIS breast microcalcifications (2022) (0)
- O-68 The effect of lymphovascular invasion (LVI) on survival (2010) (0)
- Abstract P1-16-09: Magnetic sentinel node and occult lesion localization in breast cancer: Initial results of the MagSNOLL trial (2015) (0)
- The imaging features of pure mucinous cancer of the breast (1994) (0)
- 23OClinical patterns of metastatic spread from formalin-fixed, paraffin-embedded (FFPE) expression profiles: A case-control study of 1,357 breast cancer patients (2015) (0)
- Qualitative research study interview schedules (original version) (2016) (0)
- Quality assessment tool used in the systematic review of clinical effectiveness of surveillance mammography (2011) (0)
- Example of detailed outline of economic model structure (2011) (0)
- Characteristics of the included studies for the systematic review of test performance of surveillance mammography and comparator tests in detecting IBTR/MCBC (2011) (0)
- OPTIMA prelim : optimal personalized treatment of early breast cancer using multiparameter analysis : preliminary study (2012) (0)
- Abstract P1-22-06: A longitudinal cohort study of outcomes in 311 women with unresected ductal carcinoma in situ detected through the English breast screening programme (2022) (0)
- Ductal Carcinoma in Situ (2018) (0)
- Screen-detected lobular neoplasia of the breast: Findings from the Sloane Project (2016) (0)
- Abstract PD9-06: Histopathological and molecular immune landscape and DNA damage response signatures to predict response to carboplatin and docetaxel in TNT trial TNBC cohort (2023) (0)
- Abstract P2-04-07: Immune profiling of post neoadjuvant high metastatic risk (RCB-II/III) residual disease in patients with early triple negative breast cancers (2017) (0)
- Methods: recruitment and study conduct (2016) (0)
- Chapter 3: Core biopsy – Methodologies, reporting and management issues (2011) (0)
- 0-40. Preoperative diagnosis of 249 screen detected breast cancers using a combination of core biopsy and FNAC (1997) (0)
- Pleomorphic Lobular Carcinoma In Situ, what do we know? A UK multicenter audit (2018) (0)
- 973 Which complement regulatory proteins could be a good target for a breast cancer vaccine (2003) (0)
- Author's response to reviews Title:Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer and their putative prognostic value Authors: (2015) (0)
- Summary of findings of the structured review of doubling times (2011) (0)
- Abstract 5108: Copy number analysis of pure DCIS and association with recurrence (2022) (0)
- Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
- The Supreme Court and FAISA : financial law (2013) (0)
- Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
- Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
- rural route millennium (2005) (0)
- TAD: A single centre 5-year’s experience (Guy’s Hospital, London): where are we now? (2023) (0)
- Study in progress - Pre-operative Oncotype DX testing: A decision impact study (PRE-DX) (2023) (0)
- Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
- Comparison of ER Assessment Using Three Antibodies Optimised for use with an Automated IHC Stainer System (2011) (0)
- THE PROGNOSTIC VALUE OF TISSUE FACTOR AND THROMBOSPONDIN IN PRIMARY BREAST-CARCINOMA (1995) (0)
- Cohesive cells in a breast fine needle aspirate (2000) (0)
- New molecular tools and optical technologies to dissect CXCR4 function in breast cancer (2006) (0)
- 56P Lymph node germinal centres and B cell responses in triple-negative breast cancer (2022) (0)
- Diagnosis of lymph node metastases by axillary node core biopsy in patients presenting with primary operable breast cancer (2002) (0)
- High-throughput optical proteomics and breast cancer patient profiling: novel applications to individualise prognosis and treatment (2008) (0)
- Abstract P4-09-13: Predicting Potential Patterns of Metastatic Spread and Outcomes in Breast Cancer (2010) (0)
- Use of novel optical proteomics to profile breast cancer patients leading to individualised prognosis and tailored treatment. (2016) (0)
- Abstract P4-15-02: Impact of radiotherapy and endocrine therapy on further events: Final multivariate analysis of a prospective, national cohort study of screen detected ductal carcinoma in situ (DCIS) of the breast (2018) (0)
- Methodological optimisation of intraoperative margin assessment using confocal microscopy (2022) (0)
- Subject Index: TO FOLLOW (2004) (0)
- Investing in emergent art : lifestyle art investment (2015) (0)
- The breasts (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sarah E. Pinder?
Sarah E. Pinder is affiliated with the following schools:
